Clorox (NYSE: CLX ) is expected to report Q1 earnings around Oct. 31. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 3.6% and EPS will shrink -2.0%.
The average estimate for revenue is $1.35 billion. On the bottom line, the average EPS estimate is $0.96.
Last quarter, Clorox recorded revenue of $1.54 billion. GAAP reported sales were 4.0% higher than the prior-year quarter's $1.48 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.32. GAAP EPS of $1.32 for Q4 were 4.8% higher than the prior-year quarter's $1.26 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.7%, 80 basis points worse than the prior-year quarter. Operating margin was 18.7%, 30 basis points worse than the prior-year quarter. Net margin was 11.3%, 10 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.65 billion. The average EPS estimate is $4.30.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 833 members out of 869 rating the stock outperform, and 36 members rating it underperform. Among 278 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 273 give Clorox a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $70.38.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.